Literature DB >> 20639755

Critical care trial design and interpretation: a primer.

Jonathan E Sevransky1, William Checkley, Greg S Martin.   

Abstract

OBJECTIVE: Better understanding of the pathophysiology of critical illness has led to an increase in clinical trials designed to improve the clinical care and outcomes of patients with life-threatening illness. Knowledge of basic principles of clinical trial design and interpretation will assist the clinician in better applying the results of these studies into clinical practice. DATA SOURCES: We review selected clinical trials to highlight important design features that will improve understanding of the results of critical care clinical trials designed to improve clinical care of the critically ill.
RESULTS: Trial design features such as patient selection, bias, sample size calculation, selection of subjects and controls, and primary outcome measure may influence the results of a critical care clinical trial designed to test a therapy targeting improved clinical care. In conjunction with trial design knowledge, understanding the size of the anticipated treatment effect, the importance of any clinical end point achieved, and whether patients in the trial are representative of typical patients with the illness will assist the reader in determining whether the results should be applied to specific patients or usual clinical practice.
CONCLUSIONS: Better understanding of important aspects of trial design and interpretation, such as whether patients enrolled in both intervention arms were comparable and whether the primary outcome of the trial is clinically important, will assist the bedside clinician in determining whether to apply the findings from the clinical study into clinical practice.

Entities:  

Mesh:

Year:  2010        PMID: 20639755      PMCID: PMC4247355          DOI: 10.1097/CCM.0b013e3181eae226

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  58 in total

1.  Bias and causal associations in observational research.

Authors:  David A Grimes; Kenneth F Schulz
Journal:  Lancet       Date:  2002-01-19       Impact factor: 79.321

Review 2.  Sample size calculations for randomized controlled trials.

Authors:  Janet Wittes
Journal:  Epidemiol Rev       Date:  2002       Impact factor: 6.222

3.  A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients.

Authors:  James Dean Sandham; Russell Douglas Hull; Rollin Frederick Brant; Linda Knox; Graham Frederick Pineo; Christopher J Doig; Denny P Laporta; Sidney Viner; Louise Passerini; Hugh Devitt; Ann Kirby; Michael Jacka
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

4.  The intensive care unit. A three year experience at Baltimore city hospitals.

Authors:  P SAFAR; T J DEKORNFELD; J W PEARSON; J S REDDING
Journal:  Anaesthesia       Date:  1961-07       Impact factor: 6.955

5.  One-year outcomes in survivors of the acute respiratory distress syndrome.

Authors:  Margaret S Herridge; Angela M Cheung; Catherine M Tansey; Andrea Matte-Martyn; Natalia Diaz-Granados; Fatma Al-Saidi; Andrew B Cooper; Cameron B Guest; C David Mazer; Sangeeta Mehta; Thomas E Stewart; Aiala Barr; Deborah Cook; Arthur S Slutsky
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

6.  High-frequency oscillatory ventilation for acute respiratory distress syndrome in adults: a randomized, controlled trial.

Authors:  Stephen Derdak; Sangeeta Mehta; Thomas E Stewart; Terry Smith; Mark Rogers; Timothy G Buchman; Brian Carlin; Stuart Lowson; John Granton
Journal:  Am J Respir Crit Care Med       Date:  2002-09-15       Impact factor: 21.405

7.  Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock.

Authors:  Angel López; Jose Angel Lorente; Jay Steingrub; Jan Bakker; Angela McLuckie; Sheila Willatts; Michael Brockway; Antonio Anzueto; Laurent Holzapfel; Desmond Breen; Michael S Silverman; Jukka Takala; Jill Donaldson; Carl Arneson; Geraldine Grove; Steven Grossman; Robert Grover
Journal:  Crit Care Med       Date:  2004-01       Impact factor: 7.598

8.  Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).

Authors:  Jan Bakker; Robert Grover; Angela McLuckie; Laurent Holzapfel; Jan Andersson; Robert Lodato; David Watson; Steven Grossman; Jill Donaldson; Jukka Takala
Journal:  Crit Care Med       Date:  2004-01       Impact factor: 7.598

9.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

10.  Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial.

Authors:  Christian Richard; Josiane Warszawski; Nadia Anguel; Nicolas Deye; Alain Combes; Didier Barnoud; Thierry Boulain; Yannick Lefort; Muriel Fartoukh; Frederic Baud; Alexandre Boyer; Laurent Brochard; Jean-Louis Teboul
Journal:  JAMA       Date:  2003-11-26       Impact factor: 56.272

View more
  3 in total

1.  Outcomes and statistical power in adult critical care randomized trials.

Authors:  Michael O Harhay; Jason Wagner; Sarah J Ratcliffe; Rachel S Bronheim; Anand Gopal; Sydney Green; Elizabeth Cooney; Mark E Mikkelsen; Meeta Prasad Kerlin; Dylan S Small; Scott D Halpern
Journal:  Am J Respir Crit Care Med       Date:  2014-06-15       Impact factor: 21.405

2.  Navigating the institutional review board approval process in a multicenter observational critical care study.

Authors:  Carmen C Polito; Sushma K Cribbs; Greg S Martin; Terence O'Keeffe; Dan Herr; Todd W Rice; Jonathan E Sevransky
Journal:  Crit Care Med       Date:  2014-05       Impact factor: 7.598

Review 3.  Systematic Review of the "Pragmatism" of Pragmatic Critical Care Trials.

Authors:  Jessica A Palakshappa; Kevin W Gibbs; Margo T Lannan; Anna R Cranford; Stephanie P Taylor
Journal:  Crit Care Explor       Date:  2022-07-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.